Article
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jan 2018
Noonan Sinead A, Patil Tejas, Gao Dexiang, King Gentry G, Thibault Jessica R, Lu Xian, Bunn Paul A, Doebele Robert C, Purcell W Thomas, Barón Anna E, Camidge D Ross
Abstract excerpt
INTRODUCTION: The role of serum tumor markers in the modern management of advanced NSCLC remains poorly described. METHODS: A single-center retrospective analysis of available carcinoembryonic antigen, CA125, CA19.9, and CA27.29 levels at baseline and during treatment of stage IV lung adenocarcinoma by oncogenic driver was conducted. RESULTS: A total of 142 patients were analyzed (60 with anaplastic lymphoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.